Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001897612-24-001922
Filing Date
2024-11-14
Accepted
2024-11-14 13:28:31
Documents
1
Confirming Copy
 

Document Format Files

Seq Description Document Type Size
1 cytk13gsep24.txt SC 13G 4928
  Complete submission text file 0001897612-24-001922.txt   6462
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Subject) CIK: 0001061983 (see all company filings)

EIN.: 943291317 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-79858
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 100 EAST PRATT STREET BALTIMORE MD 21202
Business Address 100 EAST PRATT STREET BALTIMORE MD 21202 000-000-0000
T. Rowe Price Investment Management, Inc. (Filed by) CIK: 0001897612 (see all company filings)

EIN.: 854328500 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SC 13G